Hunkgolden,
Over the last few years, I've literally gone through every biotech stock in the NASDAQ, almost 650 stocks. Here's a good resource:
https://topforeignstocks.com/stock-lists/the-complete-list-of-biotech-stocks-trading-on-nasdaq/
I'm in no way, shape or form an expert. Plus, we're in a long term strong bull market so that helps.
I'm not an analyst, so I'm not reading annual reports or trying to decipher complex financial data, nor am I trying to assess the viability of a particular new drug, diagnostic or whatever.
In addition, most of these stocks are not long term investments (for that, I put my long term money in Fidelity and Vanguard funds). I'm essentially looking for homeruns or short term pops, riding the momentum that stock has shown over the last 12-24 months with the expectation that it will continue assuming no negative news (typically something from the FDA) is going to derail it. I do like micro-cap developmental stage oncology stocks because they have such big potential for a huge return.
But here's what I'm looking at:
1) Stock price (I like stocks <$20 and really looking for <$10)
2) I look at 12, 18, 24 months charts. I'm looking for consistent stock price growth (not really looking at stocks that have dropped and trying to catch the bottom).
3) From that initial 650, I write down about 100 that catch my initial interest. From that, take another look at the charts, and cut that down to about 20. Of those 20, I might do a little deeper dive and finally, I might put money into 5-7 of them.
I've won some and lost some (current losers include BDSI and GERN).
I've also found the conversations on this thread to be helpful and have actually bought BLDP on a tip from 70Boiler. Made a quick profit and got out (a little early apparently).
I've shared what else I'm buying or looking at closely. AGRX being one of those. VERU also potential for a big payday.